NIRAMAI* Cancer Screening
Founded 2016 · 68 employees on LinkedIn · 4 known investors
Niramai develops an AI-based, radiation-free thermal imaging medical device (Thermalytix, SMILE-100, and Mythri) for early detection of breast cancer, offering a low-cost, portable, non-invasive screening tool for use in clinics, hospitals, and outreach camps. The technology serves healthcare providers screening women across a wide age range and is deployed in over 22 countries.
Founders & leadership
NIRAMAI* Cancer Screening was founded in 2016 by Geetha Manjunath.
GM
Geetha ManjunathinFounder and Chief Executive Officer
Board
NM
Nidhi Mathur
Investors · 4
Frequently asked questions
- What does NIRAMAI* Cancer Screening do?
- Niramai develops an AI-based, radiation-free thermal imaging medical device (Thermalytix, SMILE-100, and Mythri) for early detection of breast cancer, offering a low-cost, portable, non-invasive screening tool for use in clinics, hospitals, and outreach camps. The technology serves healthcare providers screening women across a wide age range and is deployed in over 22 countries.
- Who founded NIRAMAI* Cancer Screening?
- NIRAMAI* Cancer Screening was founded by Geetha Manjunath in 2016.
- Who are NIRAMAI* Cancer Screening's investors?
- NIRAMAI* Cancer Screening's investors include 500 Global, Ankur Capital, Axilor Ventures, pi Ventures.